Table 4.
Normal range | Clinical utility | |
---|---|---|
%HypoM [32] | < 3.4% | Indicator of IDA |
%HypoR [32] | < 3.7% | Indicator of IDA |
CHr [32] | < 25 pg | Measures functional iron available over 3–4 days, early indicator of IDA and response to iron therapy |
M/H [34] | < 3.7 | Differentiating IDA from Beta Thalassemia trait |
%HypoM %Hypochromic microcytes; %HypoR %Hypochromic reticulocytes; CHr reticulocyte hemoglobin content; M/H Microcytic RBC%/Hypochromic RBC%